ENVISTA TO ACQUIRE OSTEOGENICS BIOMEDICAL BUSINESS

BREA, Calif., May 17, 2022 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc (together “Osteogenics”). The transaction is subject to…